Differential sympathetic response to lesion-induced chronic kidney disease in rabbits.

[1]  Marc P. Bonaca,et al.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials , 2019, The Lancet.

[2]  H. Yokoi,et al.  CTGF in kidney fibrosis and glomerulonephritis , 2018, Inflammation and regeneration.

[3]  V. Liakopoulos,et al.  Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden? , 2017, Oxidative medicine and cellular longevity.

[4]  D. Power,et al.  NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy , 2017, Diabetes.

[5]  B. Wallin,et al.  Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization. , 2017, American journal of physiology. Heart and circulatory physiology.

[6]  G. Gomes,et al.  Total renal denervation reduces sympathoexcitation to different target organs in a model of chronic kidney disease , 2017, Autonomic Neuroscience.

[7]  H. Schmidt,et al.  Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy , 2016, Diabetologia.

[8]  K. Lim,et al.  Differential activation of renal sympathetic burst amplitude and frequency during hypoxia, stress and baroreflexes with chronic angiotensin treatment , 2015, Experimental physiology.

[9]  C. Hildreth,et al.  Direct conscious telemetry recordings demonstrate increased renal sympathetic nerve activity in rats with chronic kidney disease , 2015, Front. Physiol..

[10]  C. Hildreth,et al.  The effect of losartan on differential reflex control of sympathetic nerve activity in chronic kidney disease , 2015, Journal of hypertension.

[11]  R. Virmani,et al.  Anatomic assessment of sympathetic peri-arterial renal nerves in man. , 2014, Journal of the American College of Cardiology.

[12]  R. Touyz,et al.  Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. , 2014, Journal of the American Society of Nephrology : JASN.

[13]  H. Krum,et al.  Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. , 2013, International journal of cardiology.

[14]  H. Krum,et al.  Renal denervation in moderate to severe CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[15]  R. Evans,et al.  Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits , 2012, Journal of hypertension.

[16]  M. Zerani,et al.  Ovulation induction in rabbit does: current knowledge and perspectives. , 2011, Animal reproduction science.

[17]  R. Evans,et al.  Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertension , 2011, Journal of hypertension.

[18]  Giuseppe Mancia,et al.  Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure , 2011, Hypertension.

[19]  E. Lambert,et al.  New Approaches to Quantifying Sympathetic Nerve Activity , 2011, Current hypertension reports.

[20]  A. Goodchild,et al.  Cardiovascular autonomic dysfunction in a novel rodent model of polycystic kidney disease , 2010, Autonomic Neuroscience.

[21]  M. Esler,et al.  Sympathetic activation in chronic renal failure. , 2009, Journal of the American Society of Nephrology : JASN.

[22]  G. Mancia,et al.  Behaviour of regional adrenergic outflow in mild-to-moderate renal failure , 2009, Journal of hypertension.

[23]  V. Campese,et al.  Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. , 2008, Journal of applied physiology.

[24]  G. Rangan,et al.  Temporal Relationship between Renal Cyst Development, Hypertension and Cardiac Hypertrophy in a New Rat Model of Autosomal Recessive Polycystic Kidney Disease , 2007, Kidney and Blood Pressure Research.

[25]  Merlin C. Thomas,et al.  PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse , 2006 .

[26]  C. Vio,et al.  Pregnant Rats With 5/6 Nephrectomy Have Normal Volume Expansion Despite Lower Renin and Kallikrein , 2003, Hypertension.

[27]  V. Campese.  A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications , 2003, Journal of Clinical and Experimental Nephrology.

[28]  G. Head,et al.  Method for in vivo calibration of renal sympathetic nerve activity in rabbits , 2003, Journal of Neuroscience Methods.

[29]  M. Cooper,et al.  Calcitonin receptor isoforms expressed in the developing rat kidney. , 2003, Kidney international.

[30]  K. Rahn,et al.  Sympathetic Nerve Activity in End-Stage Renal Disease , 2002, Circulation.

[31]  C. Zoccali,et al.  Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease , 2002, Circulation.

[32]  G. Dibona.  Functionally specific renal sympathetic nerve fibers: role in cardiovascular regulation. , 2001, American journal of hypertension.

[33]  S. Burke,et al.  Relative Importance of Rostral Ventrolateral Medulla in Sympathoinhibitory Action of Rilmenidine in Conscious and Anesthetized Rabbits , 2001, Journal of cardiovascular pharmacology.

[34]  T. Lohmeier,et al.  Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  Geoffrey A Head,et al.  A five-parameter logistic equation for investigating asymmetry of curvature in baroreflex studies. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  J. Ricketts,et al.  A five-parameter logistic equation for investigating asymmetry of curvature in baroreflex studies. , 1999, The American journal of physiology.

[37]  G. Grassi,et al.  How to assess sympathetic activity in humans. , 1999, Journal of hypertension.

[38]  P. Blankestijn,et al.  Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. , 1999, The New England journal of medicine.

[39]  G. Cerasola,et al.  Sympathetic Activity and Blood Pressure Pattern in Autosomal Dominant Polycystic Kidney Disease Hypertensives , 1998, American Journal of Nephrology.

[40]  I. Jonsdottir,et al.  Influence of voluntary exercise on hypothalamic norepinephrine. , 1998, Journal of applied physiology.

[41]  J Ludbrook,et al.  Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.

[42]  T. Shindo,et al.  The amplitude of synchronized cardiac sympathetic nerve activity reflects the number of activated pre- and postganglionic fibers in anesthetized cats. , 1993, Journal of the autonomic nervous system.

[43]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[44]  K. Nath,et al.  Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  T. Saigusa,et al.  Norepinephrine spillover faithfully reflects renal sympathetic nerve activity in conscious rabbits. , 1991, The American journal of physiology.

[46]  P. Korner,et al.  The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. , 1985, Circulation research.

[47]  I. Ninomiya,et al.  Different cardiac and renal inhibitory and excitatory areas in rabbit hypothalamus. , 1983, The American journal of physiology.

[48]  Merlin C. Thomas,et al.  The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice , 2009, Diabetologia.

[49]  B. Gallimore,et al.  Characterization of a mouse model of chronic uremia , 2004, Urological Research.

[50]  G. Dibona,et al.  Neural control of renal function. , 1997, Physiological reviews.

[51]  W. Abraham,et al.  Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: evidence for primary sympathetic activation. , 1993, American journal of nephrology.

[52]  J. Kampine,et al.  Differential control of sympathetic activity to kidney and skeletal muscle by ventral medullary neurons. , 1992, Journal of the autonomic nervous system.

[53]  I. Ninomiya,et al.  Fundamental rhythm of renal sympathetic nerve activity in anesthetized cats. , 1992, Journal of the autonomic nervous system.

[54]  P. Korner,et al.  Reflex release of vasopressin and renin in hemorrhage is enhanced by autonomic blockade. , 1990, The American journal of physiology.

[55]  W. Anderson,et al.  Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. , 1988, Hypertension.

[56]  D. Oreopoulos,et al.  Experimental model for studies of continuous peritoneal'dialysis in uremic rabbits. , 1982, Nephron.